ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 88 filers reported holding ONCOCYTE CORP in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,544 | +10.4% | 10,000 | 0.0% | 0.00% | – |
| Q4 2022 | $3,209 | -54.2% | 10,000 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | -22.2% | 10,000 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -40.0% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $15,000 | -31.8% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $22,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 1,093,219 | $6,833,000 | 1.15% |
| HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
| CITIGROUP INC | 642 | $4,000 | 0.00% |
| Sonora Investment Management, LLC | 50 | $0 | 0.00% |
| BARCLAYS PLC | 206 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 96 | $1,000 | 0.00% |